BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25132000)

  • 21. Whole exome sequencing for a patient with Rubinstein-Taybi syndrome reveals de novo variants besides an overt CREBBP mutation.
    Yoo HJ; Kim K; Kim IH; Rho SH; Park JE; Lee KY; Kim SA; Choi BY; Kim N
    Int J Mol Sci; 2015 Mar; 16(3):5697-713. PubMed ID: 25768348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electroclinical phenotype in Rubinstein-Taybi syndrome.
    Giacobbe A; Ajmone PF; Milani D; Avignone S; Triulzi F; Gervasini C; Menni F; Monti F; Biffi D; Canavesi K; Costantino MA
    Brain Dev; 2016 Jun; 38(6):563-70. PubMed ID: 26867510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spontaneous Keloids: A Literature Review.
    Jfri A; Alajmi A
    Dermatology; 2018; 234(3-4):127-130. PubMed ID: 30114700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioral and neuropsychiatric challenges across the lifespan in individuals with Rubinstein-Taybi syndrome.
    Qu'd D; Schmitt LM; Leston A; Harris JR; Slavotinek A; Riddle I; Brightman DS; Simpson BN
    Front Genet; 2023; 14():1116919. PubMed ID: 37415602
    [No Abstract]   [Full Text] [Related]  

  • 25. Primary Diffuse Large B-Cell Lymphoma in a Patient with Rubinstein-Taybi Syndrome: Case Report and Review of the Literature.
    Sy C; Henry J; Kura B; Brenner A; Grandhi R
    World Neurosurg; 2018 Jan; 109():342-346. PubMed ID: 29042334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First case report of inherited Rubinstein-Taybi syndrome associated with a novel EP300 variant.
    López M; Seidel V; Santibáñez P; Cervera-Acedo C; Castro-de Castro P; Domínguez-Garrido E
    BMC Med Genet; 2016 Dec; 17(1):97. PubMed ID: 27964710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rubinstein-Taybi syndrome and spontaneous keloids.
    Kurwa AR
    Clin Exp Dermatol; 1979 Jun; 4(2):251-4. PubMed ID: 498578
    [No Abstract]   [Full Text] [Related]  

  • 28. Rubinstein-Taybi syndrome and spontaneous keloids.
    Goodfellow A; Emmerson RW; Calvert HT
    Clin Exp Dermatol; 1980 Sep; 5(3):369-70. PubMed ID: 7438534
    [No Abstract]   [Full Text] [Related]  

  • 29. Epigenetic factors in intellectual disability: the Rubinstein-Taybi syndrome as a paradigm of neurodevelopmental disorder with epigenetic origin.
    Lopez-Atalaya JP; Valor LM; Barco A
    Prog Mol Biol Transl Sci; 2014; 128():139-76. PubMed ID: 25410544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lacrimal caruncle nevus associated with Rubinstein-Taybi syndrome.
    Pogrzebielski A; Piwowarczyk A; Kohylarz J; Romanowska-Dixon B
    Klin Oczna; 2007; 109(7-9):330-2. PubMed ID: 18260291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of Immunological Defects in a Cohort of 97 Rubinstein-Taybi Syndrome Patients.
    Saettini F; Herriot R; Prada E; Nizon M; Zama D; Marzollo A; Romaniouk I; Lougaris V; Cortesi M; Morreale A; Kosaki R; Cardinale F; Ricci S; Domínguez-Garrido E; Montin D; Vincent M; Milani D; Biondi A; Gervasini C; Badolato R
    J Clin Immunol; 2020 Aug; 40(6):851-860. PubMed ID: 32594341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secondary hemophagocytic lymphohystiocytosis in a Rubinstein Taybi syndrome patient.
    Saettini F; Radaelli S; Ocello L; Ferrari GM; Corti P; Dell'Acqua F; Ippolito D; Foresti S; Gervasini C; Badolato R; Biondi A
    Pediatr Hematol Oncol; 2022 Feb; 39(1):74-79. PubMed ID: 34018455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association of neural axis and craniovertebral junction anomalies with scoliosis in Rubinstein-Taybi syndrome.
    Giussani C; Selicorni A; Fossati C; Ingelmo P; Canonico F; Landi A; Trezza A; Riva M; Sganzerla EP
    Childs Nerv Syst; 2012 Dec; 28(12):2163-8. PubMed ID: 22914921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High frequency of mosaic CREBBP deletions in Rubinstein-Taybi syndrome patients and mapping of somatic and germ-line breakpoints.
    Gervasini C; Castronovo P; Bentivegna A; Mottadelli F; Faravelli F; Giovannucci-Uzielli ML; Pessagno A; Lucci-Cordisco E; Pinto AM; Salviati L; Selicorni A; Tenconi R; Neri G; Larizza L
    Genomics; 2007 Nov; 90(5):567-73. PubMed ID: 17855048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rare genetic diseases, signalling pathways, and keloid scar formation.
    Lacombe D; Morice-Picard F
    Br J Dermatol; 2014 Sep; 171(3):452-3. PubMed ID: 25234063
    [No Abstract]   [Full Text] [Related]  

  • 36. Relationship between age of ear piercing and keloid formation.
    Lane JE; Waller JL; Davis LS
    Pediatrics; 2005 May; 115(5):1312-4. PubMed ID: 15867040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Barrett's Esophagus in Rubinstein-Taybi Syndrome.
    Kumar P; Thota PN
    Cureus; 2020 Nov; 12(11):e11709. PubMed ID: 33391942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Keloids. A fibroproliferative disorder of unknown etiology].
    Bock O; Mrowietz U
    Hautarzt; 2002 Aug; 53(8):515-23. PubMed ID: 12221465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemical and genetic rescue of an ep300 knockdown model for Rubinstein Taybi Syndrome in zebrafish.
    Babu A; Kamaraj M; Basu M; Mukherjee D; Kapoor S; Ranjan S; Swamy MM; Kaypee S; Scaria V; Kundu TK; Sachidanandan C
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1203-1215. PubMed ID: 29409755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Confirmation of EP300 gene mutations as a rare cause of Rubinstein-Taybi syndrome.
    Zimmermann N; Acosta AM; Kohlhase J; Bartsch O
    Eur J Hum Genet; 2007 Aug; 15(8):837-42. PubMed ID: 17299436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.